Lamm DL - Search Results

1

Preventing progression and improving survival with BCG maintenance.

Lamm DL. Lamm DL. Eur Urol. 2000;37 Suppl 1:9-15. doi: 10.1159/000052376. Eur Urol. 2000. PMID: 10575266 Review.

2

Bladder cancer, 1996.

Lamm DL, Torti FM. Lamm DL, et al. CA Cancer J Clin. 1996 Mar-Apr;46(2):93-112. doi: 10.3322/canjclin.46.2.93. CA Cancer J Clin. 1996. PMID: 8624800 Review.

3

Allium sativum (garlic) treatment for murine transitional cell carcinoma.

Riggs DR, DeHaven JI, Lamm DL. Riggs DR, et al. Among authors: lamm dl. Cancer. 1997 May 15;79(10):1987-94. doi: 10.1002/(sici)1097-0142(19970515)79:10<1987::aid-cncr21>3.0.co;2-q. Cancer. 1997. PMID: 9149027

4

Drug therapy of bacillus Calmette-Guérin sepsis.

Koukol SC, DeHaven JI, Riggs DR, Lamm DL. Koukol SC, et al. Among authors: lamm dl. Urol Res. 1995;22(6):373-6. doi: 10.1007/BF00296878. Urol Res. 1995. PMID: 7740657

5

Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-1X mRNA in bladder cancer.

Somji S, Sens MA, Lamm DL, Garrett SH, Sens DA. Somji S, et al. Among authors: lamm dl. Cancer Detect Prev. 2001;25(1):62-75. Cancer Detect Prev. 2001. PMID: 11270423

6

Enhanced immunocompetence by garlic: role in bladder cancer and other malignancies.

Lamm DL, Riggs DR. Lamm DL, et al. J Nutr. 2001 Mar;131(3s):1067S-70S. doi: 10.1093/jn/131.3.1067S. J Nutr. 2001. PMID: 11238818 Review.

7

Metallothionein isoform 3 as a potential biomarker for human bladder cancer.

Sens MA, Somji S, Lamm DL, Garrett SH, Slovinsky F, Todd JH, Sens DA. Sens MA, et al. Among authors: lamm dl. Environ Health Perspect. 2000 May;108(5):413-8. doi: 10.1289/ehp.00108413. Environ Health Perspect. 2000. PMID: 10811567 Free PMC article.

8

Keyhole limpet hemocyanin immunotherapy of bladder cancer: laboratory and clinical studies.

Lamm DL, Dehaven JI, Riggs DR. Lamm DL, et al. Eur Urol. 2000;37 Suppl 3:41-4. doi: 10.1159/000052391. Eur Urol. 2000. PMID: 10828686 Clinical Trial.

9

Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?

Lamm DL. Lamm DL. Cancer Surv. 1998;31:99-108. Cancer Surv. 1998. PMID: 15281319 Review.

10

Current trends in bladder cancer treatment.

Lamm DL, Allaway M. Lamm DL, et al. Ann Chir Gynaecol. 2000;89(3):234-41. Ann Chir Gynaecol. 2000. PMID: 11079794 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results